The Indian pharmaceutical industry has come a long way from waiting for imports of bulk drugs from global players for re-processing to becoming an industry which isdriving the product development and is breaking new grounds in medical researchworldwide.The Indian pharmaceutical industry has a unique amalgamation of two major criticalfactors that make it so attractive and thereby add impetus to its growth. These are:
The process patent regime
Price controlsThe implementation of Good Manufacturing Practices has further supplemented thegrowth of this industry which is now producing bulk drugs for all the major therapysegments, which are now most in demand. In addition to this, the competencies thatIndia has achieved in process re-engineering and organic synthesis have helped derivethe most cost-effective solutions which are also compliant with the quality standards.The purpose of this report is to provide an extensive outlook on the pharmaceuticalindustry. The
of this report are:
To study the growth and trend of Indian Pharmaceutical Industry and itscontribution to Indian economy.
To study the bottlenecks in patenting and suggest suitable measures in the lightof the problematic issues in patenting with a focus on TRIPS Agreement.
To track the significance of Mergers and Acquisitions in consolidation of Pharmaceutical Industry.The report provides a complete synopsis on the Indian pharmaceutical market and its present demographics. The reports also presents the future prospects of the industry,which is an indicative of vast potential and growth opportunities, and also the possiblechallenges that the Indian pharmaceutical industry may face ahead.3